---

---

Fresenius Kabi Deutschland GmbH is a global healthcare company that offers essential medicines and medical technology for infusion, transfusion and clinical nutrition. Our products and services are used in the therapy and care of critically and chronically ill patients. The extensive product portfolio includes generic drugs to be administered intravenously, infusion therapies, clinical nutrition and the associated medical technology products for application. In the area of transfusion technology, Fresenius Kabi offers products for the collection and processing of whole blood and blood components as well as for transfusion medicine and cell therapy. In the field of biosimilars, Fresenius Kabi develops products for oncology and autoimmune diseases.

In the 2021 financial year, the company generated sales of more than €7.0 billion. Fresenius Kabi AG is a wholly owned subsidiary of the healthcare group Fresenius SE & Co. KGaA. Fresenius Kabi employs more than 41,000 people worldwide.